Breakthroughs in non-lithium battery technology are revolutionizing energy storage, with Unigrid's sodium-ion batteries achieving a 25-year lifespan and Inlyte Energy's iron-sodium systems offering cost-effective, long-lasting solutions using abundant materials. These innovations, alongside Sunamp's thermal energy systems for industrial decarbonization, promise a future of sustainable and durable energy storage beyond traditional lithium-ion.
A new survey reveals a striking paradox: while 84% of technology decision-makers deem increased AI spending by 2026 essential for competitiveness, nearly half simultaneously feel AI is currently underperforming. This commitment to future investment, despite present shortcomings, is coupled with an overwhelming 93% demand for transparency in AI use, underscoring a growing call for ethical deployment.
Brent crude oil prices surged to $116 a barrel after President Trump threatened to "blow up" Iran's oil wells and export hub if the Strait of Hormuz remains closed. This aggressive military stance has dramatically escalated Middle East tensions, sparking market volatility and raising global concerns over energy supply stability.
Over twelve tons of KitKat bars, including a new range, were brazenly stolen during transport from Italy to Poland, leaving the truck and its entire chocolate cargo completely unaccounted for. This audacious heist has prompted Nestle to issue a supply update, signaling a significant blow to their distribution and potentially impacting the launch of new products.
Indonesian President Prabowo Subianto is currently on a pivotal state visit to Japan, seeking to significantly bolster bilateral cooperation between the two nations. This high-level engagement aims to forge stronger ties across vital sectors including trade, technology, education, and critical environmental initiatives.
A global clinical trial has revealed that mavacamten, a heart medication previously approved for adults, safely and effectively improves blood flow in the left ventricles of youth with hypertrophic cardiomyopathy. This groundbreaking finding, the first phase 3 trial of its kind for pediatric HCM, offers a precision medicine approach that could help many young patients avoid invasive open-heart surgery.
